Araris Biotech AG is based at the grow site in Au and develops novel antibody-drug conjugates for targeted chemotherapies against cancer. The team led by Dragan Grabulovski, Philipp Spycher and Isabella Attinger-Toller convinced the jury.
The Strüngmann Award is presented to outstanding entrepreneurs from Germany, Switzerland or Austria who establish revolutionary technologies in the life sciences sector. It was founded in Munich in 2024 by the brothers and investors Andreas and Thomas Strüngmann, who have delivered success in the life sciences with many entrepreneurial achievements and unique visionary investments.
We congratulate Araris Biotech on the nomination and keep our fingers crossed for the final spurt!